temozolomide,capecitabine
Not Tagged
['prodige-23', 'rectal']
#asco23: 7-year prodige-23 results indicate durable benefit of induction chemo in locally advanced #rectalcancer: #ascodailynews 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.